385 related articles for article (PubMed ID: 17434680)
1. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.
Larsen EC; Hatcher JF; Adibhatla RM
Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?
Luberto C; Hannun YA
J Biol Chem; 1998 Jun; 273(23):14550-9. PubMed ID: 9603970
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibition.
Gusain A; Hatcher JF; Adibhatla RM; Wesley UV; Dempsey RJ
Mol Neurobiol; 2012 Jun; 45(3):455-64. PubMed ID: 22415444
[TBL] [Abstract][Full Text] [Related]
4. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
Adibhatla RM; Hatcher JF; Gusain A
Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
[TBL] [Abstract][Full Text] [Related]
5. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
Girón-Calle J; Srivatsa K; Forman HJ
J Pharmacol Exp Ther; 2002 Apr; 301(1):87-94. PubMed ID: 11907161
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
Singh AT; Radeff JM; Kunnel JG; Stern PH
Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
[TBL] [Abstract][Full Text] [Related]
7. Progesterone triggers the rapid activation of phospholipase D in the amphibian oocyte plasma membrane when initiating the G2/M transition.
Kostellow AB; Ma GY; Morrill GA
Biochim Biophys Acta; 1996 Dec; 1304(3):263-71. PubMed ID: 8982272
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner.
Ito J; Nagayasu Y; Ueno S; Yokoyama S
J Biol Chem; 2002 Nov; 277(47):44709-14. PubMed ID: 12228236
[TBL] [Abstract][Full Text] [Related]
9. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
Amtmann E
Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
[TBL] [Abstract][Full Text] [Related]
10. Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells.
Meng A; Luberto C; Meier P; Bai A; Yang X; Hannun YA; Zhou D
Exp Cell Res; 2004 Jan; 292(2):385-92. PubMed ID: 14697345
[TBL] [Abstract][Full Text] [Related]
11. The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609.
Perry RJ; Ridgway ND
J Lipid Res; 2004 Jan; 45(1):164-73. PubMed ID: 13130125
[TBL] [Abstract][Full Text] [Related]
12. Methylmercury-induced toxicity is mediated by enhanced intracellular calcium through activation of phosphatidylcholine-specific phospholipase C.
Kang MS; Jeong JY; Seo JH; Jeon HJ; Jung KM; Chin MR; Moon CK; Bonventre JV; Jung SY; Kim DK
Toxicol Appl Pharmacol; 2006 Oct; 216(2):206-15. PubMed ID: 16854443
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
14. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages.
Monick MM; Carter AB; Gudmundsson G; Mallampalli R; Powers LS; Hunninghake GW
J Immunol; 1999 Mar; 162(5):3005-12. PubMed ID: 10072552
[TBL] [Abstract][Full Text] [Related]
15. Ceramide does not inhibit protein kinase C beta-dependent phospholipase D activity stimulated by anti-Fas monoclonal antibody in A20 cells.
Han J; Shin I
Cell Signal; 2000 Dec; 12(11-12):731-6. PubMed ID: 11152958
[TBL] [Abstract][Full Text] [Related]
16. PKC alpha depletion in RAW264.7 macrophages following microbial/IFNgamma stimulation is PC-PLC-mediated.
von Knethen A; Brüne B
Antioxid Redox Signal; 2005; 7(9-10):1217-22. PubMed ID: 16115026
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin.
Dai Q; Liu J; Chen J; Durrant D; McIntyre TM; Lee RM
Oncogene; 2004 Apr; 23(20):3650-8. PubMed ID: 15077187
[TBL] [Abstract][Full Text] [Related]
18. Role of sphingomyelinase in mitochondrial ceramide accumulation during reperfusion.
Ramírez-Camacho I; Bautista-Pérez R; Correa F; Buelna-Chontal M; Román-Anguiano NG; Medel-Franco M; Medina-Campos ON; Pedraza-Chaverri J; Cano-Martínez A; Zazueta C
Biochim Biophys Acta; 2016 Oct; 1862(10):1955-63. PubMed ID: 27479697
[TBL] [Abstract][Full Text] [Related]
19. D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes.
Nofer JR; Junker R; Seedorf U; Assmann G; Zidek W; Tepel M
Cell Signal; 2000 May; 12(5):289-96. PubMed ID: 10822169
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
